ci2jfq2 | Knowledge4COVID-19

Property	Value
?:abstract	Experience with very mild #COVID19 disease courses in two severe eosinophilic asthmatics with complete eosinophil depletion due to benralizumab treatment counters the recent theories that eosinophilia is protective in COVID-19 infections https://bit.ly/3cnEFvg.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/7ci2jfq2_hasAnnotation_C0242656> <https://research.tib.eu/covid-19/entity/7ci2jfq2_hasAnnotation_C3714514>
?:creator	<https://research.tib.eu/covid-19/entity/Renner%2C_Andreas%3B_Marth%2C_Katharina%3B_Patocka%2C_Karin%3B_Idzko%2C_Marco%3B_Pohl%2C_Wolfgang>
?:doi	<https://research.tib.eu/covid-19/entity/10.1183/23120541.00457-2020>
?:doi	10.1183/23120541.00457-2020
?:journal	ERJ_open_research
?:license	cc-by-nc
?:pmid	<https://research.tib.eu/covid-19/entity/33257916.0>
?:pmid	33257916.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/7ci2jfq2_HAS_C0242656_COEXISTS_WITH_C0004096> <https://research.tib.eu/covid-19/entity/7ci2jfq2_HAS_C2982078_TREATS_C0004096> <https://research.tib.eu/covid-19/entity/7ci2jfq2_HAS_C5203670_COEXISTS_WITH_C0004096>
?:source	Medline
?:title	COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth.
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-01

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/7ci2jfq2>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/7ci2jfq2>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all